Skip to main content

Table 4 Pool effects of clinicopathologic characteristics in cancer patients with abnormal SNHG5 expression

From: An increase in SNHG5 expression is associated with poor cancer prognosis, according to a meta-analysis

Clinicopathologic characteristics

No. of studies

No. of patients

Odds ratio (95% CI)

Heterogeneity

Fixed

Random

I2(%)

P-value

Age

11

801

0.96 (0.71–1.29)

0.96 (0.71–1.30)

0

0.9

Gender

7

443

0.74 (0.49–1.12)

0.76 (0.46–1.25)

25

0.35

 TNM (III + IV vs. I + II)

10

748

3.78 (2.75–5.19)

4.12 (2.62–6.46)

43

0.07

  Digestive system

6

446

4.50 (2.98–6.8)

4.49 (2.96–6.81)

0

0.59

Reproductive system

3

262

2.36 (1.38–4.03)

2.79 (1.04–7.48)

59

0.09

  Other system

1

40

16.00 (3.23–79.27)

16.00 (3.23–79.27)

–

–

 LNM (present vs. absent)

8

638

2.16 (1.56–2.99)

2.16 (0.97–4.80)

80

 < 0.0001

  Digestive system

5

376

2.24 (1.48–3.38)

2.13 (0.59–7.64)

87

 < 0.0001

Non-digestive system

3

262

2.03 (1.20–3.44)

2.12 (0.85–5.27)

64

 < 0.0001

 Tumor size

7

490

3.10 (2.13–4.50)

3.23 (2.07–5.03)

24

0.24

  Digestive system

4

228

4.11 (2.34–7.21)

4.11 (2.33–7.26)

0

0.55

  Non-digestive system

3

262

2.47 (1.50–4.08)

2.67 (1.26–5.64)

51

0.13

 Histological grade

6

498

1.85 (1.29–2.67)

1.84 (1.25–2.70)

7

0.37

  Digestive system

5

376

1.95 (1.28–2.98)

1.96 (1.18–3.26)

23

0.27

  Non-digestive system

1

122

1.59 (0.77–3.27)

1.59 (0.77–3.27)

–

–

 DM (present vs. absent)

3

296

4.61 (2.53–8.39)

4.11 (2.23–7.58)

0

0.4

 Depth of invasion

2

190

1.46 (0.83–2.58)

1.78 (0.35–9.00)

85

0.009

  1. TNM: Tumor Node Metastasis, LNM: lymph node metastasis, DM: distant metastasis, CI confidence interval,
  2. No.: number, NA: not applicable, Random: Random effect model; Fixed: Fixed effect model; I2: I-square